Taiko Pharmaceutical Co.,Ltd. (4574.T) JPX

Currency In JPY

AD

Valuation

Market Cap14.97B
Enterprise Value11.53B
P/E Ratio19.58
PEG Ratio0.3
Price/Sales Ratio2.03
Price/Book Ratio1.6
Enterprise/Revenue1.66
Enterprise/EBITDA12.44

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.1
Operating Margin0.06
AD

Management Effectiveness

Return On Assets0.06
Return On Equity0.08

Income Statement

Revenue6.4B
Revenue/Share131.74
Gross Profit3.48B
EBITDA724M
Net Income923M
Diluted EPS18.37

Balance Sheet

Total Cash3.17B
Total Cash/Share62.99
Total Debt172M
Total Debt/Equity0.02
Current Ratio5.13
Book Value Per Share167.67

Price History

52-Week Change-15.72
52-Week High322
52-Week Low246
Moving Average 50 Days264.54
Moving Average 200 Days283.7

Statistics

Average Volume112,504
Shares Outstanding50.25M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate3.3
Trailing Annual Dividend Yield1.23
Payout Ratio0
Last Split Factor3:1
Last Split DateMarch 30, 2020
AD